|
1
|
Jing F and Hongyang W: Precision diagnosis
and treatment of liver cancer in China. Cancer Letters.
412:283–288. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang H, Woo HY, Lee SK, Han JW, Jang B,
Nam HC, Lee HL, Lee SW, Song DS, Song MJ, et al: A comparative
study of sorafenib and metronomic chemotherapy for Barcelona Clinic
Liver Cancer-stage C hepatocellular carcinoma with poor liver
function. Clin Mol Hepatol. 23:128–137. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mugada V, Ramineni H and Padala D:
5-Fluorouracil induced severe febrile neutropenia and death. J
Young Pharm. 9:133–134. 2017. View Article : Google Scholar
|
|
4
|
Nematbakhsh M, Pezeshki Z, Eshraghi Jazi
F, Mazaheri B, Moeini M, Safari T, Azarkish F, Moslemi F, Maleki M,
Rezaei A, et al: Cisplatin-induced nephrotoxicity; protective
supplements and gender differences. Asian Pac J Cancer Prev.
18:295–314. 2017.PubMed/NCBI
|
|
5
|
Oun R and Rowan E: Cisplatin induced
arrhythmia; electrolyte imbalance or disturbance of the SA node?
Eur J Pharmacol. 811:125–128. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jia WX, Zhao HB, Chen GJ and Zhang CY:
Using drug thinking of Traditional Chinese Medicine on liver
cancer. Chin J Basic Med Tradi Chin Med. 23:121–123. 2017.(In
Chinese).
|
|
7
|
Guo P, Liang G and Yang S: Research
progresses of curcumol in medicine. China Med. 11:768–772. 2016.(In
Chinese).
|
|
8
|
Zang S, Tang Q, Dong F, Liu H, Li L, Guo
F, Pan X, Lin H, Zeng W, Cai Z, et al: Curcumol inhibits the
proliferation of gastric adenocarcinoma MGC-803 cells via
downregulation of IDH1. Oncol Report. 38:3583–3591. 2017.
|
|
9
|
Ling G, Xiaofang X, Xiaoping Y, Jian W and
Zhao J: Effects of curcumol-β-cyclodextrin inclusion compound on
proliferation and cell cycle of human hepatocarcinoma cell line
Bel-7404. China Mod Doct. 16:11–14. 2015.
|
|
10
|
Hossen MS, Tanvir EM, Prince MB, Paul S,
Saha M, Ali MY, Gan SH, Khalil MI and Karim N: Protective mechanism
of turmeric (Curcuma longa) on carbofuran-induced hematological and
hepatic toxicities in a rat model. Pharm Biol. 55:1937–1945. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mengqing S, Yongxing D, Zongze L, Lei Y,
Hong S and Ziwen L: 5-Fluorouracil suppresses human hepatocellular
carcinoma cell growth via promoting miR-22 expression. Basic Clin
Med. 37:1368–1372. 2017.(In Chinese).
|
|
12
|
Hua L and Dong'ang Z: Matrine injection
for enhanced sensitivity to cisplatin in chemotherapy for liver
cancer. Pract J Cancer. 32:1659–1662. 2017.(In Chinese).
|
|
13
|
Zhe M, Fang W, Xin J and Yu L:
Preformulation study of curcumol. Int Pharm Res. 43:561–563.
2016.(In Chinese).
|
|
14
|
Ting W and Xiaokun L: Study on technology
of preparation and quality evaluation of curcumol liposome. Chin
Arch Tradit Chin Med. 33:2687–2689. 2015.
|
|
15
|
Darwish WM, Bayoumi NA and El-Kolaly MT:
Laser-responsive liposome for selective tumor targeting of
nitazoxanide nanoparticles. Eur J Pharm Sci. 111:526–533. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Joseph RR, Tan DWN, Ramon MRM, Natarajan
JV, Agrawal R, Wong TT and Venkatraman SS: Characterization of
liposomal carriers for the trans-scleral transport of Ranibizumab.
Sci Rep. 7:168032017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Aryasomayajula B, Salzano G and Torchilin
VP: Multifunctional Liposomes. Methods Mol Biol. 1530:41–61. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhao M, Ding XF, Shen JY, Zhang XP, Ding
XW and Xu B: Use of liposomal doxorubicin for adjuvant chemotherapy
of breast cancer in clinical practice. J Zhejiang Univ Sci B.
18:15–26. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zununi Vahed S, Salehi R, Davaran S and
Sharifi S: Liposome-based drug co-delivery systems in cancer cells.
Mater Sci Eng C Mater Biol Appl. 71:1327–1341. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Koshy ST, Cheung AS, Gu L, Graveline AR
and Mooney DJ: Liposomal delivery enhances immune activation by
STING agonists for cancer immunotherapy. Advanced Biosystems.
1:1–19. 2017. View Article : Google Scholar
|
|
21
|
Oh HR, Jo HY, Park JS, Kim DE, Cho JY, Kim
PH and Kim KS: Galactosylated liposomes for targeted co-delivery of
Doxorubicin/Vimentin siRNA to hepatocellular carcinoma.
Nanomaterials. 6:E1412016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mbatha L, Chakravorty S, de Koning CB, van
Otterlo WA, Arbuthnot P, Ariatti M and Singh M: Spacer length: A
determining factor in the design of galactosyl ligands for hepatoma
cell-specific liposomal gene delivery. Curr Drug Deliv. 13:935–945.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Luo LH, Zheng PJ, Nie H, Chen YC, Tong D,
Chen J and Cheng Y: Pharmacokinetics and tissue distribution of
docetaxel liposome mediated by a novel galactosylated cholesterol
derivatives synthesized by lipase-catalyzed esterification in
non-aqueous phase. Drug Deliv. 23:1282–1290. 2016.PubMed/NCBI
|
|
24
|
Jiang PL, Lin HJ, Wang HW, Tsai WY, Lin
SF, Chien MY, Liang PH, Huang YY and Liu DZ: Galactosylated
liposome as a dendritic cell-targeted mucosal vaccine for inducing
protective anti-tumor immunity. Acta Biomater. 11:356–367. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
López-Terrada D, Cheung SW, Finegold MJ
and Knowles BB: HepG2 is a hepatoblastoma-derived cell line. Hum
Pathol. 40:1512–1515. 2009. View Article : Google Scholar
|
|
26
|
Cheng D, Meng M, Zhang X and Wang C: An
anti-tumor peptide from Musca Domestica Pupae (MATP) induces
apoptosis in human liver cancer cells HepG2 cells through a ROS-JNK
pathway. Internat J Pept Res Ther. 23:101–109. 2017. View Article : Google Scholar
|
|
27
|
Cui H, Li W and Lin L: Antibacterial
activity of liposome containing curry plant essential oil against
Bacillus cereus in rice. J Food Saf. 37:1–8. 2017. View Article : Google Scholar
|
|
28
|
Ping S, Chunhui Z, Jing H and Dongbin H:
The curcumol inhibitory effect on HNE1 cell of nasopharyngeal
carcinoma in tumor-bearing mouse mode. Lab Anim Sci. 34:18–22.
2017.
|
|
29
|
Zhang L, Ding L, Tang C, Li Y and Yang L:
Liraglutide-loaded multivesicular liposome as a sustained-delivery
reduces blood glucose in SD rats with diabetes. Drug Deliv.
23:3358–3363. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wenjie L, Hui L, Qiuqiang Y, Juxiang Z,
Zhenbin J and Yi C: Rapid determination of entrapment efficiency of
zedoary turmeric oil liposomes by extraction-chromogenic method. J
N Pharm. 10:3–6. 2013.
|
|
31
|
Xiao Z: Research of curcumenol intravenous
submicron emulsion. Peking Union Med Coll. 2008
|
|
32
|
Ma Y, Chen H, Su S, Wang T, Zhang C, Fida
G, Cui S, Zhao J and Gu Y: Galactose as Broad ligand for multiple
tumor imaging and therapy. J Cancer. 6:658–670. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pathak PO, Nagarsenker MS, Barhate CR,
Padhye SG, Dhawan VV, Bhattacharyya D, Viswanathan CL, Steiniger F
and Fahr A: Cholesterol anchored arabinogalactan for
asialoglycoprotein receptor targeting: Synthesis, characterization,
and proof of concept of hepatospecific delivery. Carbohydr Res.
408:33–43. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li Y, Huang G, Diakur J and Wiebe LI:
Targeted delivery of macromolecular drugs: Asialoglycoprotein
receptor (ASGPR) expression by selected hepatoma cell Lines used in
antiviral drug development. Curr Drug Deliv. 5:299–302. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu H, Hu M, Yu X, Li Y, Fu Y, Zhou X,
Zhang D and Li J: Design and evaluation of pH-sensitive liposomes
constructed by poly (2-ethyl-2-oxazoline)-cholesterol hemisuccinate
for doxorubicin delivery. Eur J Biopharm. 91:66–74. 2015.
View Article : Google Scholar
|
